Evidence map›Paper›PMID 42285589›Full record

ArticleBMJ case reports2026

Fulminant flecainide intoxication in an adolescent: cardiogenic shock requiring VA-ECMO support.

Mila Kovacevic, Ivan Bešenji, Milana Jarakovic, Jelena Radonjic, Maja Stefanovic, Branislav Crnomarkovic, Stevan Keca, Sonja Dimic, Snezana Bjelica, Ilija Srdanovic

Abstract readCase Reports
In one paragraph

Article in BMJ case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mila KovacevicCardilology, Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica, Serbia.
Ivan BešenjiCardilology, Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica, Serbia Besenjiivan@gmail.com.
Milana JarakovicCardilology, Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica, Serbia.
Jelena RadonjicCardilology, Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica, Serbia.
Maja StefanovicCardilology, Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica, Serbia.
Branislav CrnomarkovicCardilology, Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica, Serbia.
Stevan KecaCardilology, Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica, Serbia.
Sonja DimicCardilology, Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica, Serbia.
Snezana BjelicaCardilology, Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica, Serbia.
Ilija SrdanovicCardilology, Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe the case of a previously healthy adolescent female who presented with chest discomfort and near-syncope, accompanied by trifascicular block and hypotension. Her clinical condition rapidly progressed to cardiogenic shock with neurological impairment. Despite multiple attempts, transvenous pacing failed to achieve consistent ventricular capture. Flecainide intoxication was subsequently confirmed through toxicological analysis. The patient was managed with invasive ventilation, veno-arterial extracorporeal membrane oxygenation (VA-ECMO), sodium bicarbonate and intravenous lipid emulsion therapy, resulting in full neurological and cardiac recovery following a prolonged intensive care unit stay. Flecainide overdose is rare but associated with high mortality due to profound conduction abnormalities and shock. Early recognition and timely escalation to advanced mechanical circulatory support, including VA-ECMO, are critical for survival.Learning points. Prompt identification and advanced haemodynamic support are lifesaving in severe flecainide intoxication, clinicians should consider VA-ECMO early in refractory cases.

Indexed as

Anti-Arrhythmia AgentsExtracorporeal Membrane OxygenationFlecainideShock, CardiogenicAdolescentDrug OverdoseElectrocardiographyFat Emulsions, IntravenousFemaleHumansSodium BicarbonateTreatment OutcomeAnti-Arrhythmia AgentsFat Emulsions, IntravenousFlecainideSodium BicarbonateArrhythmiasCardiovascular medicineInterventional cardiologyMechanical ventilationPacing and electrophysiology

Identifiers

PMID42285589
PMCPMC13288401

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.